156 related articles for article (PubMed ID: 30425509)
1. Prognostic value of NEK2 overexpression in digestive system cancers: a meta-analysis and systematic review.
Ren Q; Li B; Liu M; Hu Z; Wang Y
Onco Targets Ther; 2018; 11():7169-7178. PubMed ID: 30425509
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of NEK2 in human solid tumors: a systematic review and meta-analysis.
Wang X; Chen K; Liu H; Huang Z; Chen X; Yin L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30578380
[TBL] [Abstract][Full Text] [Related]
3. NIMA-related kinase 2 overexpression is associated with poor survival in cancer patients: a systematic review and meta-analysis.
Yao Y; Su J; Zhao L; Luo N; Long L; Zhu X
Cancer Manag Res; 2019; 11():455-465. PubMed ID: 30655697
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of S100P Expression in Patients With Digestive System Cancers: A Meta-Analysis.
Liu BX; Tang CT; Dai XJ; Zeng L; Cheng F; Chen Y; Zeng C
Front Oncol; 2021; 11():593728. PubMed ID: 33747914
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological utility of PD-L2 expression in patients with digestive system cancers: A meta-analysis.
Lin X; Lin K; Lin C; Wang J; Tang Y
Int Immunopharmacol; 2020 Nov; 88():106946. PubMed ID: 33182023
[TBL] [Abstract][Full Text] [Related]
7. The predictive role of soluble programmed death ligand 1 in digestive system cancers.
Ruan J; Zhao Z; Qian Y; Xu R; Liao G; Kong FS
Front Oncol; 2023; 13():1170220. PubMed ID: 37519785
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
[No Abstract] [Full Text] [Related]
11. Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis.
Li MX; Bi XY; Huang Z; Zhao JJ; Han Y; Li ZY; Zhang YF; Li Y; Chen X; Hu XH; Zhao H; Cai JQ
PLoS One; 2015; 10(5):e0127356. PubMed ID: 26024373
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis.
Zhang D; Liu Z; Yin X; Qi X; Lu B; Liu Y; Hou J
Int J Biol Markers; 2018 Aug; 33(3):266-274. PubMed ID: 29658364
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of miR17-92 family in patients with digestive system cancers: a systematic review and meta-analysis.
Zhang X; Zhang S; He Q; Gao X; Yang L; Xu P; Zhao R; Wang Q; Zhang L; Zhao P
Cancer Manag Res; 2019; 11():1043-1058. PubMed ID: 30774432
[TBL] [Abstract][Full Text] [Related]
14. Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.
Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y
World J Urol; 2020 Jan; 38(1):129-142. PubMed ID: 30919100
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and Clinicopathological Significance of MiR-155 in Hematologic Malignancies: A Systematic Review and Meta-analysis.
Tang L; Peng YZ; Li CG; Jiang HW; Mei H; Hu Y
J Cancer; 2019; 10(3):654-664. PubMed ID: 30719163
[No Abstract] [Full Text] [Related]
16. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
17. TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis.
Wang J; Du S; Fan W; Wang P; Yang W; Yu M
Oncotarget; 2017 Sep; 8(43):75516-75527. PubMed ID: 29088887
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
Zhong P; Hua H; Chen S; Zhu Z; Xie F
Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis.
Zhu L; Sun J; Wang L; Li Z; Wang L; Li Z
Front Pharmacol; 2019; 10():962. PubMed ID: 31616289
[No Abstract] [Full Text] [Related]
20. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
